| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Cogan John Francis is a Director at GILD. Recent filings cover 0 purchases and 28 sales. Those positions are worth an estimated $7.9M at current prices.
Cogan John Francis's largest disclosed position is in GILD as Director, worth about $7.9M. The recent filings there lean toward selling, a net 103,231 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,833 | $74.47 | $434,383.51 | -10.0% | |
| Apr 2, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,833 | $74.93 | $437,066.69 | -10.0% | |
| Mar 23, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,833 | $75.02 | $437,587.58 | -10.0% | |
| Mar 16, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,833 | $80.09 | $467,137.55 | -10.0% | |
| Mar 12, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 5,833 | $80.93 | $472,064.69 | -10.0% | |
| May 9, 2017 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 9,943 | $67.25 | $668,666.75 | -15.9% |